These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15008220)

  • 1. [Medical record. Diabetic nephropathy].
    Rev Prat; 2003 Nov; 53(18):2050. PubMed ID: 15008220
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diabetic nephropathy].
    Morcos M; Zeier M; Schwenger V
    Dtsch Med Wochenschr; 2007 May; 132(19):1039-42. PubMed ID: 17476634
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diabetic nephropathy].
    Koya D; Kashiwagi A
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():625-9. PubMed ID: 15779451
    [No Abstract]   [Full Text] [Related]  

  • 4. Microvascular benefits of hypertension and glucose control in type 2 diabetes.
    van Rensburg BW
    Cardiovasc J Afr; 2008; 19(4):179-80. PubMed ID: 18776957
    [No Abstract]   [Full Text] [Related]  

  • 5. [A 20-year prospective follow-up study to evaluate the development of retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory].
    Bolotskaya LL; Bessmertnaya EG; Shestakova MV; Shamkhalova MS; Nikankina LV; Ilyin AV; Glek IS; Zolotukhin AV; Dedov II
    Ter Arkh; 2017; 89(10):17-21. PubMed ID: 29171465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Type 1 diabetes: long-term effects of intensive insulin therapy on diabetic retinopathy and nephropathy].
    Letonturier P
    Presse Med; 2000 Mar; 29(11):598. PubMed ID: 10776417
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention and protection in diabetic nephropathy].
    Lidén MK
    Lakartidningen; 2013 May 22-28; 110(21):1025-7. PubMed ID: 23805766
    [No Abstract]   [Full Text] [Related]  

  • 8. Postprandial hyperglycaemia--its importance and implications.
    Lüddeke HJ
    Int J Clin Pract Suppl; 1999 Jul; 104():3-7; discussion 18-20. PubMed ID: 12669731
    [No Abstract]   [Full Text] [Related]  

  • 9. Preventing or postponing renal disease in insulin-dependent diabetes by glycemic and nonglycemic intervention.
    Mogensen CE; Hansen KW
    Contrib Nephrol; 1990; 78():73-100; discussion 100-1. PubMed ID: 2225845
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nephroprotection in patients with diabetes mellitus].
    Fischereder M
    MMW Fortschr Med; 2017 Sep; 159(15):60-62. PubMed ID: 28924706
    [No Abstract]   [Full Text] [Related]  

  • 11. [Protection of renal function in diabetics].
    Hasslacher C
    Internist (Berl); 2007 Jul; 48(7):686, 688-90, 692 passim. PubMed ID: 17579824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [How to prevent diabetic nephropathy or to delay its development].
    Grzeszczak W
    Pol Arch Med Wewn; 1995 Jul; 94(1):1-7. PubMed ID: 8524693
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal involvement in type 1 (IDDM) diabetes in Spain. ESTUDIO DIAMANTE.
    Diabetes Res Clin Pract; 1997 Nov; 38(2):129-37. PubMed ID: 9483377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Compliance with the 2002 consensus document of the Spanish Society of Nephrology for the control of diabetic nephropathy in Catalonia (ECCODIAB)].
    Fontseré N; Bonal J; Torres F; de las Cuevas X; Fort J
    Nefrologia; 2006; 26(6):679-87. PubMed ID: 17227245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium-glucose co-transporter type 2 inhibitors reduce evening home blood pressure in type 2 diabetes with nephropathy.
    Takenaka T; Kishimoto M; Ohta M; Tomonaga O; Suzuki H
    Diab Vasc Dis Res; 2017 May; 14(3):258-261. PubMed ID: 28467199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to predict nephropathy in type 1 diabetic patients.
    Dash R; Torffvit O
    Scand J Urol Nephrol; 2003; 37(5):437-42. PubMed ID: 14594696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of antihypertensive combinations on arterial pressure, albuminuria, and glycemic control in patients with type II diabetic nephropathy: a randomized study].
    Goicolea I; Fernández González R; Piniés J; Garrido J; Martínez JM; Armenteros S; Moreno Carretero E
    Nefrologia; 2002; 22(2):170-8. PubMed ID: 12085418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of Angiopoietin-2 and vascular endothelial growth factor as markers of diabetic nephropathy onset in Egyptians diabetic patients with non-albuminuric state.
    Aly MH; Arafat MA; Hussein OA; Elsaid HH; Abdel-Hammed AR
    Diabetes Metab Syndr; 2019; 13(2):1623-1627. PubMed ID: 31336531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of diabetic dialysis patients].
    Kaizu K; Abe M; Matsumoto K
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():434-8. PubMed ID: 15999748
    [No Abstract]   [Full Text] [Related]  

  • 20. Retinopathy in patients with type 1 diabetes 4 years after intensive therapy.
    Bressler SB; Bressler NM
    Arch Ophthalmol; 2000 Jul; 118(7):984-5. PubMed ID: 10910526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.